vimarsana.com

Page 149 - அமெரிக்கன் கல்லூரி ஆஃப் மகப்பேறியல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Covid-19 vaccine does not make people dangerous to others

Copyright AFP 2017-2021. All rights reserved. Social media posts claim that people vaccinated against Covid-19 pose a health risk to those who have not been immunized by “shedding” spike proteins. But experts say this is impossible, and that there is also no proof for the claim that the shots affect fertility. “Stay Away From Them,” says an April 19, 2021 video post on Instagram by a woman who presents herself as a nurse. Screenshot of an Instagram post taken on April 29, 2021 The video has also been shared on Facebook, Rumble and BitChute. Similarclaims have been circulating on social media, and a Florida private school barred teachers who have been vaccinated against Covid-19 from coming into contact with students, citing misinformation about the shots as justification.

ObsEva SA presents posters at the ACOG Annual Clinical and Scientific Virtual Meeting April 30

ObsEva SA presents posters at the ACOG Annual Clinical and Scientific Virtual Meeting April 30 - May 2, 2021 - ObsEva SA (NASDAQ: OBSV / SIX: OBSN) a biopharmaceutical company developing and commercializing novel therapies to improve women s reproductive health, today announced the presentation of five e-Posters on linzagolix in the treatment of uterine fibroids at the American College of Obstetricians and Gynecologists (ACOG) Annual Clinical and Scientific Meeting (ACSM), which will take place virtually from April 30 to May 2, 2021. The data presented further substantiate the best-in-class potential of linzagolix for the treatment of heavy menstrual bleeding (HMB) due to uterine fibroids addressing both key efficacy and safety parameters from the PRIMROSE Phase 3 program.

New Efficacy Data Reinforces NEXTSTELLIS® Benefits Across Patient Populations

New Efficacy Data Reinforces NEXTSTELLIS® Benefits Across Patient Populations Results presented at the 2021 American College of Obstetricians and Gynecologists Annual Clinical and Scientific Meeting News provided by Share this article Share this article GREENVILLE, N.C., April 30, 2021 /PRNewswire/ Mayne Pharma announced today results from two studies showing treatment with NEXTSTELLIS® (3 mg drospirenone [DRSP] and 14.2 mg estetrol [E4] tablets) demonstrated contraceptive efficacy and excellent cycle control across subgroups, including age, body mass index (BMI)[1] and prior contraceptive use. NEXTSTELLIS is the first contraceptive pill containing E4, a new naturally occurring estrogen with a unique mechanism of action that offers potential advantages over other estrogens. The findings were presented at the 2021 American College of Obstetricians and Gynecologists (ACOG) Annual Clinical and Scientific Meeting, held virtually in the U.S. from April 30 – May 2.

Birth centers aren t as safe as hospitals for childbirth, researchers say, challenging top gynecology organization s stance

Birth centers aren t as safe as hospitals for childbirth, researchers say, challenging top gynecology organization s stance INSIDER 4/30/2021 © Crystal Cox/Business Insider Crystal Cox/Business Insider A research presentation linked birth center deliveries with higher infant death and seizure rates. The study challenges the American College of Obstetricians and Gynecologists position that birth centers are among the safest places to deliver. Research comparing birthplace settings is flawed, and birth centers benefits are well-documented, experts say. A subset of pregnant women have long sought out birth centers - low-tech, women-centered facilities typically staffed by midwives - for a childbirth experience that promises few medical interventions, a homey environment, and a model of care that views birth as a normal human experience, not an illness that needs to be treated.

Q&A with Anthony Fauci, Cameron Webb on your COVID-19 vaccine questions

Commercial Appeal: I m joined today by Dr. Anthony Fauci, chief medical advisor to the White House and director of the National Institute of Allergy and Infectious Diseases. Along with us is Dr. Cameron Webb, senior policy advisor to the White House on COVID-19 equity. Thank you both for taking the time today to answer some vaccine-related questions for our readers. I wanted to start off with some questions about fertility. That was one of the most common topics readers wanted us to ask you about. So, do any of the COVID-19 vaccines currently available have any impact on fertility? And what would your advice be to women who are concerned about getting the vaccine because they re pregnant or trying to conceive?

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.